Huazhong Pharmaceutical Co., Ltd. is located in Xiangyang City, Hubei Province, a famous historical city in the country. It is the only large-scale pharmaceutical company affiliated with China Ordnance Equipment Group Corporation. The factory was built in Gucheng County, Hubei Province in 1968. It was formerly known as the state-owned Hongshan Chemical Plant. In October 1987, the Third Line Office of the State Council approved the transfer of a new pharmaceutical project to Xiangfan City and named it the state-owned Huazhong Pharmaceutical Factory. In 2002, the debt was completed. Share transfer and restructuring, Hubei Huazhong Pharmaceutical Co., Ltd. was established; in December 2010, the State-owned Assets Supervision and Administration Commission of the State Council approved the share reform plan and completed the industrial and commercial registration of Huazhong Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"). In 1987, it switched from military products to pharmaceuticals for 20 years Over the years, the company has gradually developed from a single API manufacturing plant into a large-scale comprehensive pharmaceutical enterprise group, starting from small batch production and manufacturing in the initial stage. Complete quality system and high brand value.

The company passed the GMP system certification as a whole in 2003; the leading product vitamin B1 has passed the quality management system ISO9001:2001 version, the food safety management system ISO22000:2005 version organized by the British Lloyd's Register certification company, and the European Union organization The feed additive and food additive production quality management system FAMI-QS and the food safety control system HACCP have been certified; the "Huayi" trademark has become a famous trademark in Hubei Province, and the vitamin B1 product has been rated as a famous brand product in Hubei Province. Complete varieties and specifications, and large-scale leading products.

After the reorganization of Hu Yao, the company has nearly 300 pharmaceutical preparation products in 9 categories including antibiotics, vitamins, family planning, psychiatric, cardiovascular and cerebrovascular, hormones, antipyretic and analgesic, with dosage forms covering tablets and capsules agents, granules, and injections. Among them, the annual production capacity of the leading product vitamin B1 API is currently the largest manufacturer in the world; the annual production capacity of pharmaceutical preparations is the largest preparation manufacturer in the province. Broad sales channels and high market share. APIs are sold domestically in 28 provinces, municipalities and autonomous regions, and exported to more than 20 countries and regions including the United States, Britain, France, Germany, Southeast Asia, and Hong Kong, and are listed as inspection-free products in Southeast Asia and Hong Kong markets; preparation products are sold domestically in more than 20 provinces, cities, and Autonomous Region, exported to more than a dozen countries and regions including Russia, Africa, Southeast Asia and Cuba. In accordance with China Ordnance Group Corporation's "211 Strategy" and "Twelfth Five-Year Plan", the company has begun to fully implement a new round of development strategy for the next six years - "5321 Strategy". By 2015, on the basis of 2009 , built five major product bases, tripled profits, quadrupled sales revenue, and doubled employee income. The Central China Industrial Park is under construction and has a solid foundation for future development. The Huazhong Pharmaceutical Industrial Park, with a total investment of 3 billion yuan, was newly built by the company in accordance with the strategic plan of China Military Equipment Group Corporation and Xiangyang City to revitalize the pharmaceutical industry to create a pharmaceutical industry of 10 billion yuan in Xiangyang. In accordance with the requirements for equipment upgrades, technology upgrades and product upgrades, the project adopts the construction model of "overall planning, rolling development, and phased implementation". It is planned to complete the construction of all projects in the industrial park in 2015, forming a "vitamin", "spiritual", The five pharmaceutical product bases of "antibiotics and antipyretics and analgesics", "steroids" and "finished drugs" have achieved sales revenue of 5 billion yuan and strive to reach the goal of 10 billion yuan. Facing the future, Huazhong Pharmaceutical closely follows the development requirements of the times, aiming to create a world-famous brand and building a first-class pharmaceutical enterprise, taking Everbright Pharmaceuticals and caring for human health as its corporate purpose, and continues to occupy the commanding heights of pharmaceutical technology through technological innovation. , and strive to build the company into a large pharmaceutical enterprise group with strong international competitiveness.